PL3371150T3 - Sposób wytwarzania briwaracetamu - Google Patents
Sposób wytwarzania briwaracetamuInfo
- Publication number
- PL3371150T3 PL3371150T3 PL16787866T PL16787866T PL3371150T3 PL 3371150 T3 PL3371150 T3 PL 3371150T3 PL 16787866 T PL16787866 T PL 16787866T PL 16787866 T PL16787866 T PL 16787866T PL 3371150 T3 PL3371150 T3 PL 3371150T3
- Authority
- PL
- Poland
- Prior art keywords
- brivaracetam
- preparing
- preparing brivaracetam
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15192760 | 2015-11-03 | ||
| PCT/EP2016/075935 WO2017076738A1 (en) | 2015-11-03 | 2016-10-27 | Process for preparing brivaracetam |
| EP16787866.9A EP3371150B1 (en) | 2015-11-03 | 2016-10-27 | Process for preparing brivaracetam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3371150T3 true PL3371150T3 (pl) | 2022-01-17 |
Family
ID=54476761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16787866T PL3371150T3 (pl) | 2015-11-03 | 2016-10-27 | Sposób wytwarzania briwaracetamu |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10421717B2 (pl) |
| EP (1) | EP3371150B1 (pl) |
| CY (1) | CY1124587T1 (pl) |
| DK (1) | DK3371150T3 (pl) |
| ES (1) | ES2893301T3 (pl) |
| HR (1) | HRP20211518T1 (pl) |
| HU (1) | HUE056380T2 (pl) |
| LT (1) | LT3371150T (pl) |
| PL (1) | PL3371150T3 (pl) |
| PT (1) | PT3371150T (pl) |
| RS (1) | RS62472B1 (pl) |
| SI (1) | SI3371150T1 (pl) |
| WO (1) | WO2017076738A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017025266A2 (pt) | 2015-05-25 | 2018-08-07 | Suzhou Pengxu Pharmatech Co Ltd | processo para produzir brivaracetam |
| WO2018220646A1 (en) * | 2017-05-29 | 2018-12-06 | Msn Laboratories Private Limited, R&D Center | An improved process for the preparation of (2s)-2-[(4r)-2-oxo-4-propyltetrahydro-1h-pyrrol-1-yl] butanamide and its intermediates thereof |
| CN108101823A (zh) * | 2018-02-13 | 2018-06-01 | 扬州奥锐特药业有限公司 | 一种高手性纯度内酰胺中间体及布瓦西坦的制备方法 |
| CN108147988B (zh) * | 2018-02-13 | 2020-10-02 | 扬州奥锐特药业有限公司 | 一种高手性纯度内酰胺化合物的制备方法 |
| CN108101824B (zh) * | 2018-02-13 | 2020-04-03 | 扬州奥锐特药业有限公司 | 一种高手性纯度内酰胺中间体及布瓦西坦的制备方法 |
| CN111333563B (zh) * | 2018-12-19 | 2023-11-07 | 上海科胜药物研发有限公司 | 一种布瓦西坦中间体的制备方法 |
| CN111122736B (zh) * | 2019-12-30 | 2021-03-12 | 北京鑫开元医药科技有限公司海南分公司 | 一种用于检测布瓦西坦中间体中对映异构体的方法 |
| CN111187175A (zh) * | 2020-01-08 | 2020-05-22 | 上海朴颐化学科技有限公司 | 一种利用微通道反应器氢化制备布瓦西坦的中间体的方法 |
| LV15614A (lv) | 2020-07-30 | 2022-02-20 | Latvijas Organiskās Sintēzes Institūts | 2-(2-okso-3-pirolin-1-il)acetamīdi kā pretkrampju līdzekļi |
| CN114394921A (zh) * | 2022-02-22 | 2022-04-26 | 浙江九洲药业股份有限公司 | 一种高纯度布瓦西坦的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| ZA200601970B (en) | 2003-09-24 | 2007-05-30 | Ucb Sa | Process for preparing 2-oxo-1-pyrrolidine derivatives |
| EP2053040A1 (en) * | 2007-10-26 | 2009-04-29 | Chemo Ibérica, S.A. | Pregabalin intermediates and process for preparing them and Pregabalin |
-
2016
- 2016-10-27 HU HUE16787866A patent/HUE056380T2/hu unknown
- 2016-10-27 PT PT167878669T patent/PT3371150T/pt unknown
- 2016-10-27 PL PL16787866T patent/PL3371150T3/pl unknown
- 2016-10-27 WO PCT/EP2016/075935 patent/WO2017076738A1/en active Application Filing
- 2016-10-27 LT LTEPPCT/EP2016/075935T patent/LT3371150T/lt unknown
- 2016-10-27 ES ES16787866T patent/ES2893301T3/es active Active
- 2016-10-27 US US15/772,607 patent/US10421717B2/en active Active
- 2016-10-27 EP EP16787866.9A patent/EP3371150B1/en active Active
- 2016-10-27 SI SI201631365T patent/SI3371150T1/sl unknown
- 2016-10-27 RS RS20211198A patent/RS62472B1/sr unknown
- 2016-10-27 HR HRP20211518TT patent/HRP20211518T1/hr unknown
- 2016-10-27 DK DK16787866.9T patent/DK3371150T3/da active
-
2021
- 2021-10-14 CY CY20211100890T patent/CY1124587T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20190119206A1 (en) | 2019-04-25 |
| PT3371150T (pt) | 2021-11-05 |
| ES2893301T3 (es) | 2022-02-08 |
| EP3371150B1 (en) | 2021-08-18 |
| SI3371150T1 (sl) | 2021-11-30 |
| RS62472B1 (sr) | 2021-11-30 |
| LT3371150T (lt) | 2021-11-25 |
| HRP20211518T1 (hr) | 2021-12-24 |
| HUE056380T2 (hu) | 2022-02-28 |
| US10421717B2 (en) | 2019-09-24 |
| CY1124587T1 (el) | 2022-07-22 |
| WO2017076738A1 (en) | 2017-05-11 |
| DK3371150T3 (en) | 2021-11-15 |
| EP3371150A1 (en) | 2018-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
| HUE059158T2 (hu) | Eljárás pridopidin elõállítására | |
| ZA201701415B (en) | Process for preparing pyrazoles | |
| IL274439A (en) | Process for making Tapinaroff | |
| RS62472B1 (sr) | Postupak pripreme brivaracetama | |
| HK1247097A1 (zh) | 用於製備氟酮內酯的方法 | |
| IL253877A0 (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
| SI3160984T1 (sl) | Postopek za pripravo D-arginil-2,6-dimetil-L-tirosil-L-lisil-L-fenilalaninamida | |
| GB201608083D0 (en) | Process for preparing boscalid | |
| IL255977B (en) | A new process for the preparation of enzalutamide | |
| ZA201908452B (en) | Improved process for preparing imetelstat | |
| GB2536979B (en) | Process for preparing boscalid | |
| PL3156381T4 (pl) | Sposób wytwarzania granulek | |
| IL249283A0 (en) | Process for the preparation of 3-chloro-2-vinylphenol | |
| GB2539022B (en) | Process for preparing boscalid | |
| GB2552699B (en) | Process for preparing boscalid | |
| ZA201807441B (en) | Process for preparing oxathiazin-like compounds | |
| ZA201803631B (en) | Improved process for making crotonylaminopyridines | |
| GB2552696B (en) | Process for preparing boscalid |